Among different heterocyclic chemotypes incorporating two nitrogen atoms, pyrazolines could be considered a valid pharmacophore for the synthesis of selective monoamine oxidase (MAO) inhibitors because they were developed by the cyclization of the early hydrazine derivatives such as isocarboxazid. Substituted pyrazolines, decorated with different functional groups, are important lead compounds endowed with a large amount of biological activities. As a matter of this, most of them were also evaluated as dual inhibitors with a synergistic action towards different classes of enzymes (ciclooxygenase, acetylcholinesterase, butyrylcholinesterase). Moreover due to the direct correlation with the recognized MAO inhibition, this scaffold displayed antidepressant and anticonvulsant properties in animal models.

Discovery and optimization of pyrazoline derivatives as promising monoamine oxidase inhibitors

MACCIONI, ELIAS
2012

Abstract

Among different heterocyclic chemotypes incorporating two nitrogen atoms, pyrazolines could be considered a valid pharmacophore for the synthesis of selective monoamine oxidase (MAO) inhibitors because they were developed by the cyclization of the early hydrazine derivatives such as isocarboxazid. Substituted pyrazolines, decorated with different functional groups, are important lead compounds endowed with a large amount of biological activities. As a matter of this, most of them were also evaluated as dual inhibitors with a synergistic action towards different classes of enzymes (ciclooxygenase, acetylcholinesterase, butyrylcholinesterase). Moreover due to the direct correlation with the recognized MAO inhibition, this scaffold displayed antidepressant and anticonvulsant properties in animal models.
Alzheimer's disease; Antidepressant agents; Isocarboxazid; Monoamine oxidase; Parkinson's disease; Pyrazoline; Drug Discovery3003 Pharmaceutical Science
File in questo prodotto:
File Dimensione Formato  
Discovery and optimization of pyrazoline derivatives as promising monoamine oxidase inhibitors.pdf

Solo gestori archivio

Tipologia: versione editoriale
Dimensione 2.84 MB
Formato Adobe PDF
2.84 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11584/141107
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 47
  • ???jsp.display-item.citation.isi??? 43
social impact